October 7, 2024
Katie Shen
Share
https://www.sciencedirect.com/science/article/pii/S2589555924000995
A Phase 3 Biomarker Validation of GALAD for the Detection of Hepatocellular Carcinoma in Cirrhosis
March 9, 2026
Semaglutide Improves Histology in MASH: Phase 3 ESSENCE Trial
January 20, 2026
Can fecal microbiota transplant be used for hepatic encephalopathy ? The THEMATIC trial
November 17, 2025
